สหรัฐอเมริกา - อังกฤษ - NLM (National Library of Medicine)

merit pharmaceutical - thiamine hydrochloride (unii: m572600e5p) (thiamine ion - unii:4abt0j945j), riboflavin 5'-phosphate sodium (unii: 20rd1dzh99) (flavin mononucleotide - unii:7n464ure7e), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), dexpanthenol (unii: 1o6c93ri7z) (dexpanthenol - unii:1o6c93ri7z), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4) - thiamine hydrochloride 100 mg in 1 ml - indications and usage:   in disorders requiring parenteral administration of vitamins, i.e. pre- and post-operative treatment, when requirements are increased as in fever, severe burns, increased metabolism, pregnancy, gastrointestinal disorders interfering with intake or absorption of vitamins, prolonged or wasting diseases, alcoholism and where other deficiencies exist. contraindications: sensitivity to the ingredients listed.

สหรัฐอเมริกา - อังกฤษ - NLM (National Library of Medicine)

mylan institutional llc - thiamine hydrochloride (unii: m572600e5p) (thiamine ion - unii:4abt0j945j), riboflavin 5'-phosphate sodium (unii: 20rd1dzh99) (flavin mononucleotide - unii:7n464ure7e), dexpanthenol (unii: 1o6c93ri7z) (dexpanthenol - unii:1o6c93ri7z), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z) - thiamine 100 mg in 1 ml - in disorders requiring parenteral administration of vitamins, i.e. pre- and post-operative treatment, when requirements are increased as in fever, severe burns, increased metabolism, pregnancy, gastrointestinal disorders interfering with intake or absorption of vitamins, prolonged or wasting diseases, alcoholism and where other deficiencies exist. sensitivity to the ingredients listed.

สหรัฐอเมริกา - อังกฤษ - NLM (National Library of Medicine)

raw materials international overseas llc - riboflavin 5'-phosphate sodium (unii: 20rd1dzh99) (riboflavin - unii:tlm2976ofr), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), dexpanthenol (unii: 1o6c93ri7z) (dexpanthenol - unii:1o6c93ri7z), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4), thiamine hydrochloride (unii: m572600e5p) (thiamine ion - unii:4abt0j945j) - riboflavin 2 mg in 1 ml - in disorders requiring parenteral administration of vitamins, i.e. pre- and post-operative treatment, when requirements are increased as in fever, severe burns, increased metabolism, pregnancy, gastrointestinal disorders interfering with intake or absorption of vitamins, prolonged or wasting diseases, alcoholism and where other deficiencies exist. sensitivity to the ingredients listed.

สหราชอาณาจักร - อังกฤษ - MHRA (Medicines & Healthcare Products Regulatory Agency)

accord-uk ltd - nicotinamide; pyridoxine hydrochloride; riboflavin; thiamine hydrochloride - oral tablet - 20mg ; 2mg ; 2mg ; 5mg

สหราชอาณาจักร - อังกฤษ - MHRA (Medicines & Healthcare Products Regulatory Agency)

de pharmaceuticals - nicotinamide; pyridoxine hydrochloride; riboflavin; thiamine hydrochloride - oral tablet - 20mg ; 2mg ; 2mg ; 5mg

แทนซาเนีย - อังกฤษ - Tanzania Medicinces & Medical Devices Authority

bimeda amea limited, - vitamin a , vitamin d3 , vitamin e , thiamine , pyridoxine , riboflavine , vitamin b12 , niacinamide , phosphate sodium , d-panthenol , d-biotin , cal - solution for injection - vitamin a 2000 iu/ml, vitamin d3 2000 iu/ml, vitamin e acetate 4 mg/ml, thiamine hydrochloride 10 mg/ml, pyridoxine hydrochloride 5 mg/ml, riboflavine 0.04 mg/ml, nicotinamide 10 mg/ml, vitamin b12 10 mcg/ml, phosphate sodium 1 mg/ml, d-panthenol 1 mg/ml,

ไอร์แลนด์ - อังกฤษ - HPRA (Health Products Regulatory Authority)

essential pharmaceuticals limited - riboflavin; biotin; thiamine hydrochloride; acetomenaphthone; nicotinamide; pyridoxine hydrochloride; ascorbic acid; folic acid; tocopherol acetate; inositol; calcium pantothenate - tablet - 0 percent volume/volume - vitamin b-complex, other combinations

มอลตา - อังกฤษ - Malta Medicines Authority

wallace manufacturing chemists limited 51-53 stert street, abingdon, ox14 3jf, united kingdom - folic acid, ascorbic acid, ferrous sulfate, exsiccated, nicotinamide, thiamine hydrochloride, riboflavin - soft capsule - folic acid 1.7 mg ascorbic acid 15 mg ferrous sulfate exsiccated 195 mg nicotinamide 10 mg thiamine hydrochloride 1 mg riboflavin 2 mg - antianemic preparations

ออสเตรเลีย - อังกฤษ - Department of Health (Therapeutic Goods Administration)

orthomolecular medisearch laboratories pty ltd trading as biological therapies - thiamine hydrochloride, quantity: 5 mg/ml; riboflavine sodium phosphate, quantity: 2.5 mg/ml; nicotinamide, quantity: 50 mg/ml; dexpanthenol, quantity: 10 mg/ml; pyridoxine hydrochloride, quantity: 25 mg/ml - injection, solution - excipient ingredients: disodium edetate; water for injections - b vitamin deficiencies may exist that are unable to be corrected by oral intake and in these cases parenteral administration may be preferable. oral administration of b vitamins may be insufficient in; alcoholism, pernicious anaemia, malabsorption disorders, gastrectomy, gastrointestinal pathologies and debilitated and elderly patients. specific indications include: 1. rapid saturation of the b group vitamins. 2. when oral administration is not feasible or appropriate. 3. for alcoholic, debilitated and elderly patients when their diet is inadequate. 4. patients requiring parenteral b vitamin therapy who cannot tolerate intramuscular injections. 5. recovery from beriberi and wernicke's syndrome as a result of vitamin b1 deficiency. please note that iv b-dose 2ml injection does not contain sufficient thiamine for acute treatment of wernicke's syndrome. 6. pellagra as a result of vitamin b3 deficiency. patients with pellagra may have a concurrent deficiency of b1, b2 and b6. 7. peripheral neuritis caused by vari

ออสเตรเลีย - อังกฤษ - Department of Health (Therapeutic Goods Administration)

orthomolecular medisearch laboratories pty ltd trading as biological therapies - thiamine hydrochloride, quantity: 10 mg/ml; riboflavine sodium phosphate, quantity: 2.5 mg/ml; pyridoxine hydrochloride, quantity: 5 mg/ml; dexpanthenol, quantity: 2.5 mg/ml; nicotinamide, quantity: 25 mg/ml; cyanocobalamin, quantity: 0.5 mg/ml - injection, solution - excipient ingredients: water for injections - b vitamin deficiencies may exist that are unable to be corrected by oral intake and in these cases parenteral administration may be preferable. oral administration of b vitamins may be insufficient in; alcoholism, pernicious anaemia, malabsorption disorders, gastrectomy, gastrointestinal pathologies and debilitated and elderly patients. commonly, several b vitamin deficiencies may occur similtaneously. specific indications include: 1. rapid saturation of the b group vitamins. 2. when oral administration is not feasible or appropriate. 3. for alcoholic, debilitated and elderly patients when their diet is inadequate. 4. recovery from beriberi and wernicke's syndrome as a result of vitamin b1 deficiency. please note that b-dose 2ml injection does not contain sufficient thiamine for acute treatment of wernicke's syndrome. 5. pellagra as a result of vitamin b3 deficiency. patients with pellagra may have a concurrent deficiency of b1, b2, b6 and b12. 6. peripheral neuritis caused by various b group deficiencies. 7.